Lincoln National Corp Illumina, Inc. Transaction History

Lincoln National Corp

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$127.73 - $147.2 $359,687 - $414,515	2,816 New	2,816 $386,000
Q2 2022 Aug 02, 2022	SELL	$181.58 - $368.0 $114,758 - $232,576	-632 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$303.87 - $423.8 $64,724 - $90,269	-213 Reduced 25.21%	632 $221,000
Q4 2021 Jan 26, 2022	SELL	$347.28 - $421.83 $10,418 - $12,654	-30 Reduced 3.43%	845 $322,000
Q3 2021 Nov 05, 2021	SELL	$405.61 - $524.84 $6,489 - $8,397	-16 Reduced 1.8%	875 $354,000
Q2 2021 Aug 13, 2021	BUY	$372.84 - $481.5 $51,079 - $65,965	137 Added 18.17%	891 $421,000
Q1 2021 May 10, 2021	BUY	$361.28 - $504.76 $26,373 - $36,847	73 Added 10.72%	754 $290,000
Q3 2020 Nov 09, 2020	BUY	$268.51 - $400.74 $20,675 - $30,856	77 Added 12.75%	681 $211,000
Q2 2020 Jul 31, 2020	BUY	$256.46 - $373.01 $154,901 - $225,298	604 New	604 $224,000
Q1 2020 Apr 24, 2020	SELL	$209.2 - $335.53 $168,196 - $269,766	-804 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$288.29 - $335.49 $14,414 - $16,774	50 Added 6.63%	804 $267,000
Q3 2019 Nov 06, 2019	BUY	$266.84 - $378.23 $26,683 - $37,823	100 Added 15.29%	754 $229,000
Q1 2019 May 15, 2019	BUY	$272.57 - $321.18 $178,260 - $210,051	654 New	654 $203,000
Q4 2018 Feb 08, 2019	SELL	$272.46 - $366.54 $178,733 - $240,450	-656 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$279.04 - $367.06 $183,050 - $240,791	656 New	656 $241,000
Q1 2018 May 09, 2018	SELL	$209.54 - $253.91 $261,505 - $316,879	-1,248 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$202.23 - $230.03 $252,383 - $287,077	1,248	1,248 $273,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.